U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. Division of Oncology 3 (DO3)
  1. Center for Drug Evaluation and Research (CDER)

Division of Oncology 3 (DO3)

The Division of Oncology 3 (DO3) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for Gastrointestinal, Superficial cutaneous cancers, melanoma and sarcoma.

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Oncology 3 (DO3)
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-2330
Fax: (301) 796-9845

Resources For You

Back to Top